Table 3.
Remission of comorbidities between groups.
| SG (n = 83) |
RYGB (n = 152) |
OAGB (n = 123) |
p-Value | |
|---|---|---|---|---|
| 1 year postoperative | ||||
| T2D (N, %) | 68 (81.9%) | 127 (83.6%) | 114 (91.9%) | 0.038 |
| HT (N, %) | 41 out of 53 (77.4%) | 80 out of 95 (84.2%) | 72 out of 81 (88.9%) | 0.200 |
| DL (N, %) | 22 out of 49 (44.9%) | 79 out of 96 (82.3%) | 76 out of 76 (100%) | 0.001 |
| 2 years postoperative | ||||
| T2D (N, %) | 66 (79.5%) | 127 (83.6%) | 114 (91.9%) | 0.018 |
| HT (N, %) | 39 out of 53 (73.6%) | 80 out of 95 (84.2%) | 71 out of 81 (87.6%) | 0.097 |
| DL (N, %) | 19 out of 49 (38.8%) | 78 out of 96 (81.2%) | 76 out of 76 (100%) | 0.001 |
| 5 years postoperative | ||||
| T2D (N, %) | 63 (75.9%) | 122 (80.3%) | 110 (89.4%) | 0.029 |
| HT (N, %) | 32 out of 53 (60.4%) | 69 out of 95 (72.6%) | 65 out of 81 (80.2%) | 0.086 |
| DL (N, %) | 13 out of 49 (26.5%) | 67 out of 96 (69.8%) | 76 out of 76 (100%) | 0.001 |
T2D: type 2 diabetic; HT: hypertension; DL: dyslipidemia.